Daniel Dignard

Title: The Innovations of Daniel Dignard

Introduction

Daniel Dignard is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of biotechnology, particularly in the area of protein processing and enzyme activity. With a total of 2 patents, Dignard's work has implications for both scientific research and commercial applications.

Latest Patents

Dignard's latest patents include innovative methods for screening UDP-glucose:glycoprotein glucosyltransferase (UGGT) activity. This invention relates to a method for determining the effect of a test sample on UGGT activity. The method involves exposing an acceptor substrate of UGGT to a labeled donor in the presence of the test sample and UGGT. The detection of donor transfer to the acceptor substrate allows researchers to identify whether the test sample acts as a UGGT stimulator or inhibitor. Additionally, he has developed a patent concerning a protease for the specific processing of secreted proteins in genetically modified yeast cells. This invention highlights the cloning of the KEX1 gene, which is essential for the processing of certain proteins and peptides of commercial importance.

Career Highlights

Throughout his career, Dignard has worked with prominent organizations such as Canadian Patents & Development Ltd. and the National Research Council of Canada. His experience in these institutions has allowed him to advance his research and contribute to the field of biotechnology.

Collaborations

Dignard has collaborated with notable individuals in his field, including Howard Bussey and Aleksandra Dmochowska. These collaborations have likely enriched his research and led to further innovations.

Conclusion

Daniel Dignard's contributions to biotechnology through his patents and collaborations demonstrate his commitment to advancing scientific knowledge and practical applications. His work continues to influence the field and pave the way for future innovations.